Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

St. Jude Agrees To Pay $39m To Settle Shareholder Suit

Executive Summary

The settlement, which does not include an admission of fault, puts an end to a long-running class action claim filed by investors who say they were misled by St. Jude’s failure to announce FDA safety concerns around the company’s Durata heart leads.

Advertisement

Related Content

The Rumors Were True: Abbott Buys St. Jude For $25b To Create Third Cardiovascular Giant
Another St. Jude ICD Lead Recall, But Impact May Be Limited
St. Jude Warning Letter Adds More Pressure On Firm’s Leads Division

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register